HPLC-Fluorescence Detection Method for Concurrent Estimation of Domperidone and Naproxen. Validation and Eco-Friendliness Appraisal Studies
- PMID: 36538143
- PMCID: PMC10140086
- DOI: 10.1007/s10895-022-03067-1
HPLC-Fluorescence Detection Method for Concurrent Estimation of Domperidone and Naproxen. Validation and Eco-Friendliness Appraisal Studies
Abstract
This work demonstrates a simple and reliable HPLC method with fluorimetric detection for simultaneous estimation of domperidone (DOM) and naproxen (NAP). Successful chromatographic separation was accomplished using Inertsil ODS C18 column (5 μm, 4.6 × 150 mm) with gradient elution of the mobile phase consisting of 0.01 M phosphate buffer (pH 5.5) solution and acetonitrile. The gradient elution started with 25% acetonitrile increased linearly to 65% in 5 min, then kept at this percentage till the end of the run. The mobile phase was pumped at a flow rate of 1.0 mL/min. The excitation wavelength at 284 nm was found suitable for both DOM and NAP since it corresponds to a maximum for the minor component DOM and measurable excitation for NAP, while using 316 and 355 nm as emission wavelengths for DOM and NAP, respectively. Peaks eluted with excellent resolution at retention times 4.4 and 6.3 min for DOM and NAP, respectively. Performance of the proposed method was tested according to ICH guidelines in regard to linearity, ranges, precision, accuracy, robustness, detection and quantitation limits. Calibration curves were linear in the ranges of 0.8-3.6 and 1.0-2.5 µg/mL for DOM and NAP respectively with correlation coefficients not less than 0.9996. The validated method was successfully applied to the analysis of DOM and NAP in their laboratory prepared tablets resembling the commercial dosage form, and assay results were favorably compared with a published reference HPLC method. The method's greenness was assessed using the Analytical Eco-Scale and the novel Analytical Greenness metric (AGREE).
Keywords: Domperidone; Fluorimetric detection; Greenness assessment; HPLC; Naproxen.
© 2022. The Author(s).
Conflict of interest statement
Authors declare that they have no conflict of interest.
Figures
References
-
- Sweetman SC (2014) Martindale, The Complete Drug Reference, Volume A, 38th edn. Pharmaceutical Press, London, 98–100, 1838–1839
-
- Singh S, Sharma S, Yadav AK, Gautam H. Simultaneous estimation of Naproxen and Domperidone using UV spectrophotometry in tablet dosage form. Bull Pharm Res. 2013;3(2):66–70.
-
- Tarannum A, Rizwan SH. Stability indicating method development and validation of simultaneous estimation of Domperidone and Naproxen in bulk and tablet dosage by RP HPLC. Indo Am J Pharm Sci. 2018;5(11):11719–11728.
-
- Bhaskar KL, Lakshmi DS, Sumalatha G, Suji G, Kumar KAT. Q-analysis and simultaneous equation method for estimation of domperidone and naproxen by UV spectrophotometry in bulk and tablet dosage form. Res J Pharm Technol. 2020;13(12):6050–6054. doi: 10.5958/0974-360X.2020.01054.9. - DOI
-
- Mahaparale SP, Mohite MT, Telekone RS, Mahaparale PR, Mankeshwar AA, Kasture PV. Simultaneous spectrophotometric estimation of domperidone and naproxen in tablet dosage form. Indian Drugs. 2009;46(6):61–64.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
